The relationship between comorbidity medication adherence and health related quality of life among patients with cancer

• Egile Nagusiak: Dana Drzayich Antol (Egilea), Adrianne Waldman Casebeer (Egilea), Raya Khoury (Egilea), Todd Michael (Egilea), Andrew Renda (Egilea), Sari Hopson (Egilea), Aparna Parikh (Egilea), Alisha Stein (Egilea), Mary Costantino (Egilea), Stephen Stemkowski (Egilea), Mikele Bunce (Egilea)
• Formatua: Liburua
• Argitaratua: SpringerOpen, 2018-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Studies have demonstrated that comorbidities compound the adverse influence of cancer on health-related quality of life (HRQoL). Comorbidities adversely impact adherence to cancer treatment. Additionally, adherence to medications for comorbidities is positively associated with HR...